Status:
COMPLETED
Methadone vs Magnesium in Spinal Fusion
Lead Sponsor:
Nationwide Children's Hospital
Conditions:
Idiopathic Scoliosis
Eligibility:
All Genders
12-19 years
Phase:
PHASE2
Brief Summary
Significant pain may occur following posterior spinal fusion despite the use of conventionally accepted techniques including patient controlled analgesia. If detected, a significant reduction in opioi...
Eligibility Criteria
Inclusion
- Patients older than 12, and younger than 19 years of age undergoing posterior spinal fusion for idiopathic scoliosis
- American Society of Anesthesiologist (ASA) physical status I or II
- Parents/Guardian willing and able to authorize informed consent
- Patients willing and able to authorize assent
Exclusion
- Patients presenting with neuromuscular scoliosis
- Patients deemed at increased risk of adverse reactions due to the presence of pre-existing severe organ system dysfunction, including debilitating lung disease, severe obstructive sleep apnea, severe congenital or acquired heart disease, and/or severe renal impairment
- Patients who are both being currently treated for a psychological disorder and have a history of hospitalization for said disorder
Key Trial Info
Start Date :
September 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2016
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT01795495
Start Date
September 1 2013
End Date
September 1 2016
Last Update
February 8 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nationwide Children's Hospital
Columbus, Ohio, United States, 43205